Acromegaly
📧 Sign up to get email alerts when something new happens for Acromegaly.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-09-27Clinical Trial Update: Efficacy and Safety Study of Octreotide Implant in Patients With Acromegaly [Phase 3]
A Phase 3 trial evaluating an octreotide implant for acromegaly was terminated.
-
CLINICAL_TRIALS trial_result · 2013-01-21Clinical Trial Update: Peripheral Metabolic Effects of Somatostatin [NA]
The study reports the completed results of a trial assessing the peripheral metabolic effects of somatostatin in patients with acromegaly, g…
-
CLINICAL_TRIALS trial_result · 2012-07-26Clinical Trial Update: Cardiac and Skeletal Muscle Energy Metabolism in Abnormal Growth Hormone States
This completed clinical trial studied cardiac and skeletal muscle energy metabolism in people with abnormal growth hormone states, including…
-
CLINICAL_TRIALS trial_result · 2012-05-28Clinical Trial Update: Effects of Growth Hormone Administration on Cardiovascular Risk in Cured Acromegalics With Growth Hormone Deficiency [NA]
Clinical trial assessing the effects of growth hormone administration on cardiovascular risk in individuals cured of acromegaly with growth …
-
CLINICAL_TRIALS trial_result · 2012-04-30Clinical Trial Update: Safety and Efficacy of Octreotide Long Acting Release (LAR) in Treatment Naïve Acromegalic Patients [Phase 3]
A Phase 3 trial evaluated the safety and efficacy of octreotide long-acting release (LAR) in treatment-naïve acromegaly patients and the stu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-04-26Clinical Trial Update: Study Assessing the Efficacy and Safety of Octreotide Acetate in Patients With Acromegaly, With Micro or Macroadenomas [Phase 4]
A Phase 4 study evaluating octreotide acetate for acromegaly with micro or macroadenomas was terminated.
-
CLINICAL_TRIALS trial_result · 2012-04-11Clinical Trial Update: Safety and Efficacy of Long-acting Repeatable Octreotide Acetate for Injectable Suspension vs. Surgery in Treatment-naïve Patients With Acromegaly [Phase 3]
A Phase 3 clinical trial completed evaluating the safety and efficacy of long-acting repeatable octreotide acetate injectable suspension ver…
-
CLINICAL_TRIALS trial_result · 2012-01-26Clinical Trial Update: Co-treatment With Pegvisomant and a Somatostatin Analogue (SA) in SA-responsive Acromegalic Patients [NA]
Completed clinical trial evaluating co-treatment with pegvisomant and a somatostatin analogue in acromegaly patients with insulin resistance…
-
CLINICAL_TRIALS trial_result · 2011-07-14Clinical Trial Update: Open Label Study of Octreotide Implant in Patients With Acromegaly [Phase 2]
An open-label Phase 2 clinical trial evaluated an octreotide implant for acromegaly. The study has completed.
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: Efficacy/Safety of Octreotide Acetate in Patients With Uncontrolled Acromegaly [Phase 3]
Phase 3 trial evaluating the efficacy and safety of octreotide acetate in patients with uncontrolled acromegaly has completed and results ha…
-
CLINICAL_TRIALS trial_result · 2011-02-17Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Sandostatin LAR at High Dose or in Combination Either With GH-receptor Antagonist or Dopamine-agonist in Acromegalic Patients [Phase 4]
Phase 4 trial evaluating high-dose Sandostatin LAR alone or in combination with a growth hormone receptor antagonist or a dopamine agonist i…
-
CLINICAL_TRIALS trial_result · 2010-12-20Clinical Trial Update: Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel [Phase 3]
Phase 3 trial assessing the ability of subjects with acromegaly or their partners to administer Somatuline Autogel.
-
CLINICAL_TRIALS trial_result · 2010-09-24Clinical Trial Update: Changes of Left Ventricular Mass and Cardiac Function in Patients With Active Acromegaly During Treatment With the Growth Hormone Receptor Antagonist Pegvisomant [Phase 4]
This Phase 4 trial update investigates changes in left ventricular mass and cardiac function in patients with active acromegaly who are trea…
-
CLINICAL_TRIALS trial_result · 2010-02-09Clinical Trial Update: Safety and Biological Activity of C2L-OCT-01 PR in Acromegalic Patients [Phase 3]
Phase 3 trial evaluating safety and biological activity of C2L-OCT-01 PR in acromegaly was terminated.
-
CLINICAL_TRIALS trial_result · 2009-11-17Clinical Trial Update: Short and Long Term Efficacy of Combined Cabergoline and Octreotide Treatment in Acromegalic Patients
This clinical trial update reports the completed evaluation of short- and long-term efficacy for combining cabergoline with octreotide in pa…
-
CLINICAL_TRIALS trial_result · 2009-10-12Clinical Trial Update: Preoperative Lanreotide Treatment in Acromegalic Patients With Macroadenomas [Phase 2]
This document provides an update on a Phase 2 trial evaluating preoperative lanreotide for patients with acromegaly and macroadenomas.
-
CLINICAL_TRIALS trial_result · 2009-09-02Clinical Trial Update: Cardiac Function and Morphology Evaluated by Magnetic Resonance Imaging in Growth Hormone Deficiency and Acromegaly
A completed clinical trial evaluating cardiac structure and function by MRI in individuals with growth hormone deficiency and acromegaly.
-
CLINICAL_TRIALS trial_result · 2009-08-12Clinical Trial Update: Non Interventional Study For Patients Treated With Somavert®
Pfizer conducted a non-interventional study of patients treated with Somavert (pegvisomant) for acromegaly; the study is completed and resul…
-
CLINICAL_TRIALS trial_result · 2009-06-04Clinical Trial Update: Open Label Extension Study Evaluating Safety and Biological Activity of C2L-OCT-01 PR in Acromegalic Patients [Phase 3]
An open-label extension study in acromegaly evaluating the safety and biological activity of C2L-OCT-01 PR in a Phase 3 setting has complete…
-
CLINICAL_TRIALS trial_result · 2008-10-08Clinical Trial Update: Efficacy and Safety of C2L-OCT-01 PR in Acromegalic Patients [Phase 3]
Phase 3 trial update on the efficacy and safety of C2L-OCT-01 PR in acromegaly patients; the study has completed.
-
CLINICAL_TRIALS trial_result · 2008-07-29Clinical Trial Update: Long Term Study With B2036-PEG [Phase 3]
Pfizer reports the long-term Phase 3 study of B2036-PEG in acromegaly has completed.
-
CLINICAL_TRIALS trial_result · 2008-06-23Clinical Trial Update: Impact of Somatostatin Analogs vs. Surgery on Glucose Metabolism in Acromegaly
This completed trial compares somatostatin analog therapy versus surgical treatment on glucose metabolism in acromegaly.
-
CLINICAL_TRIALS trial_result · 2008-04-24Clinical Trial Update: Canadian Pegvisomant Compassionate Study In Acromegalic Patients [Phase 4]
Pfizer's pegvisomant compassionate-use Phase 4 study in acromegaly patients has completed in Canada.
-
CLINICAL_TRIALS trial_result · 2008-04-07Clinical Trial Update: Pegvisomant And Sandostatin LAR Combination Study [Phase 4]
Phase 4 study evaluating pegvisomant in combination with Sandostatin LAR for acromegaly has completed.
-
CLINICAL_TRIALS trial_result · 2008-04-07Clinical Trial Update: A Study To Compare The Efficacy And Safety Of Pegvisomant To That Of Sandostatin Lar Depot In Patients With Acromegaly [Phase 4]
A Phase 4 trial comparing pegvisomant to Sandostatin LAR Depot for efficacy and safety in acromegaly has completed.